Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
2017 · Nature · 1,801 citations
https://doi.org/10.1038/nature22364
G
Gary Middleton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
458
Papers
29.6K
Citations
69
h-index
171
i10-index
Gary Middleton is an academic researcher from University Hospitals Birmingham NHS Foundation Trust. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations. The author has an h-index of 69, co-authored 390 publications.
ORCID: 0000-0001-5695-3474Papers by this author
worksLung adenocarcinoma promotion by air pollutants
2023 · Nature · 683 citations
https://doi.org/10.1038/s41586-023-05874-3
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
2020 · The Lancet Oncology · 599 citations
https://doi.org/10.1016/s1470-2045(20)30442-3
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
2013 · The Lancet Oncology · 597 citations
https://doi.org/10.1016/s1470-2045(13)70549-7
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma
2012 · JAMA · 574 citations
https://doi.org/10.1001/jama.2012.7352
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
2011 · Cancer Immunology Immunotherapy · 563 citations
https://doi.org/10.1007/s00262-011-1028-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat